HB

Hx Bio Ventures

Europe, Nordrhein-Westfalen, Germany, Düsseldorf

Description

Hx Bio Ventures invests in early-stage companies developing next-generation biologics.

Investor Profile

Hx Bio Ventures has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hx Bio Ventures frequently co-invest with?

NRW.BANK
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 1
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
VB
North America, Georgia, United States, Germany
Co-Investments: 1
GR
Europe, Nordrhein-Westfalen, Germany, Essen
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
coparion
Europe, Nordrhein-Westfalen, Germany, Cologne
Co-Investments: 1

What are some of recent deals done by Hx Bio Ventures?

Abalos Therapeutics

Essen, Nordrhein-Westfalen, Germany

Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.

Biotechnology
Series AOct 14, 2021
Amount Raised: $35,930,240